MARKET

BBC

BBC

Virtus LifeSci Biotech Clinical Trls ETF
NYSEARCA
28.07
0.00
0.00%
Opening 16:00 04/11 EDT
OPEN
--
PREV CLOSE
27.37
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
31.99
52 WEEK LOW
16.88
TOTAL ASSET
11.26M
YTD YIELD
30.37%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BBC last week (0401-0405)?
Weekly Report · 4d ago
Weekly Report: what happened at BBC last week (0325-0329)?
Weekly Report · 04/01 11:57
Weekly Report: what happened at BBC last week (0318-0322)?
Weekly Report · 03/25 12:01
Weekly Report: what happened at BBC last week (0311-0315)?
Weekly Report · 03/18 11:58
Weekly Report: what happened at BBC last week (0304-0308)?
Weekly Report · 03/11 11:54
Why Biotech Stocks May Be Ready For A Recovery
Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.
Seeking Alpha · 03/09 08:59
5 Best ETF Areas of Last Week
NASDAQ · 03/05 13:42
Top & Flop ETF Areas of Wall Street's Best February in Decade
NASDAQ · 03/04 13:00
More
Profile
Fund Name
Virtus LifeSci Biotech Clinical Trls ETF
Inception Date
2014-12-16
Benchmark
LifeSci Biotech Clinical Trials USD
Advisor Company
Virtus ETF Advisers LLC
Custodian
Bank of New York Mellon
Manager
Matthew Brown, Seth Kadushin